Profile data is unavailable for this security.
About the company
Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company; Synairgen Inc. and Synairgen Research (Ireland) Limited. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for the treatment and prevention of various viral lung infections in high-risk patient groups. The Company has developed and is testing an inhaled formulation of IFN-B designed to directly target the lungs, the primary site of many viral lung infections, including COVID-19.
- Revenue in GBP (TTM)0.00
- Net income in GBP-9.99m
- Incorporated2004
- Employees30.00
- LocationSynairgen PLCSouthampton General Hosp, Tremona RoadSOUTHAMPTON SO16 6YDUnited KingdomGBR
- Phone+44 23 8051 2800Fax+44 23 8051 2800
- Websitehttps://www.synairgen.com/
More ▼
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
ImmuPharma PLC | 69.96k | -2.99m |
Cambridge Nutritional Sciences PLC | 9.05m | -3.21m |
Bivictrix Therapeutics PLC | 0.00 | -2.33m |
Proteome Sciences plc | 5.03m | -2.44m |
Chill Brands Group PLC | 146.62k | -3.64m |
Kanabo Group PLC | 813.00k | -4.66m |
Abingdon Health PLC | 5.34m | -2.24m |
Synairgen plc | 0.00 | -9.99m |
Incanthera PLC | 0.00 | -1.48m |
Genincode PLC | 1.72m | -6.73m |
Shield Therapeutics PLC | 7.21m | -46.89m |
Provexis plc | 598.08k | -496.59k |
Destiny Pharma PLC | 0.00 | -5.66m |
Oncimmune Holdings PLC | 1.15m | -6.15m |
Verici DX PLC | 15.17k | -8.95m |
OptiBiotix Health PLC | 689.10k | -13.17m |
Data as of May 02 2024. Currency figures normalised to Synairgen PLC's reporting currency: UK Pound GBX
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
TFG Asset Management UK LLPas of 26 Apr 2023 | 56.70m | 28.15% |
Toscafund Asset Management LLPas of 31 Dec 2022 | 1.28m | 0.64% |
Premier Fund Managers Ltd.as of 30 Apr 2023 | 0.00 | 0.00% |
Data from 30 Sep 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.